A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma.
about
Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphomaProphylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapyInflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients--analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO.Efficacy and toxicity of PACEBOM chemotherapy in relapsed/refractory aggressive lymphoma in the rituximab era.Identification of potential surrogate end points in randomized clinical trials of aggressive and indolent non-Hodgkin's lymphoma: correlation of complete response, time-to-event and overall survival end pointsTreatment of the elderly patient with diffuse large B cell lymphoma.Risk of chemotherapy-induced neutropenic complications when treating patients with non-Hodgkin lymphoma.Patterns of growth factor usage and febrile neutropenia among older patients with diffuse large B-cell non-Hodgkin lymphoma treated with CHOP or R-CHOP: the Intergroup experience (CALGB 9793; ECOG-SWOG 4494).Re: personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy.Immunohistochemical prognostication in diffuse large B-cell lymphoma: a single center 6-year retrospective analysis.Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
P2860
Q24240753-BA6E9975-F78B-4E17-95BE-C682C844B184Q24241680-C33DEF76-5CF6-4490-BF1E-3021B8F69EF0Q33384548-D74C511B-0409-418C-A67D-566759909D0AQ33437806-CFB3D8EF-7ADC-4179-AF95-DF94C74F9BFDQ35004750-87707E80-FF51-4E18-953D-78D5BD990DB3Q37998553-ED8D3051-D4FE-433A-86AD-78F3E83E6862Q38711166-2825DA0A-A99A-437A-8068-032D10E40201Q40410427-76307BFA-0EB6-4EC1-AAE1-449AF65532D2Q43026530-F8D34CA5-FF88-4BE9-A3DA-0B07298CB441Q44607738-D11DD5DC-BEF0-472C-99FB-F36FC74653F8Q53165773-8B4E8FE1-61DD-4F2D-9A22-F944A50BB6DB
P2860
A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A phase III trial comparing CH ...... essive non-Hodgkin's lymphoma.
@ast
A phase III trial comparing CH ...... essive non-Hodgkin's lymphoma.
@en
type
label
A phase III trial comparing CH ...... essive non-Hodgkin's lymphoma.
@ast
A phase III trial comparing CH ...... essive non-Hodgkin's lymphoma.
@en
prefLabel
A phase III trial comparing CH ...... essive non-Hodgkin's lymphoma.
@ast
A phase III trial comparing CH ...... essive non-Hodgkin's lymphoma.
@en
P2093
P2860
P356
P1476
A phase III trial comparing CH ...... essive non-Hodgkin's lymphoma.
@en
P2093
D Milligan
K MacLennan
M J S Dyer
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602975
P407
P577
2006-03-01T00:00:00Z
P5875
P6179
1017966731